Table 4.
Variables | Group | Baseline | 16 weeks | Within Group (Bonferroni) | ||
---|---|---|---|---|---|---|
| ||||||
Mean ± SD | Mean ± SD | Mean difference | SE | Sig. | ||
HbA1C | Control | 8.92 ± 2.004 | 8.81 ± 2.003 | 0.100 | 0.183 | 0.587 |
Experimental | 9.22 ± 2.130 | 7.92 ± 1.71 | 1.292,** | 0.183 | <0.001 | |
VA | Control | 0.108 ± 0.134 | 0.098 ± 0.135 | 0.010 | 0.019 | 0.587 |
Experimental | 0.083± 0.105 | 0.089 ± 0.133 | -0.006 | 0.019 | 0.745 | |
VR | Control | 6.22 ± 6.273 | 5.33 ± 6.266 | 0.898 | 0.831 | 0.282 |
Experimental | 4.73 ± 4.974 | 2.57 ± 4.153 | 2.163* | 0.831 | 0.011 | |
VM | Control | 6.00 ± 8.193 | 7.31 ± 8.583 | -1.306 | 0.845 | 0.125 |
Experimental | 5.53 ± 6.465 | 2.82 ± 4.671 | 2.714* | 0.845 | 0.002 | |
VE | Control | 2.96 ± 3.297 | 3.35 ± 4.635 | -0.388 | 0.495 | 0.435 |
Experimental | 3.29 ± 4.397 | 2.47 ± 3.703 | 0.816 | 0.495 | 0.102 | |
Total VRQoL | Control | 15.18 ± 15.34 | 15.98 ± 16.71 | -0.796 | 1.77 | 0.654 |
Experimental | 13.55 ± 14.61 | 7.86 ± 11.07 | 5.694* | 1.77 | 0.002 |
Notes:
p <0.001,
p <0.05